المؤلفون: Luigi Francesco Iannone, Luigi Bennardo, Caterina Palleria, Roberta Roberti, Caterina De Sarro, Maria Diana Naturale, Stefano Dastoli, Luca Donato, Antonia Manti, Giancarlo Valenti, Domenico D'Amico, Santo D'Attola, Adele Emanuela De Francesco, Vincenzo Bosco, Eugenio Donato Di Paola, Steven Paul Nisticò, Rita Citraro, Emilio Russo, Giovambattista De Sarro

المصدر: PLoS ONE, Vol 15, Iss 11, p e0241575 (2020)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1932-6203Test

الوصول الحر: https://doaj.org/article/a4e6b65ae6bf448eb3dbad3ea9a21dc4Test

المؤلفون: Eugenio Donato Di Paola, Luca Donato, Vincenzo Bosco, Rita Citraro, Luigi Francesco Iannone, Steven Paul Nisticò, Santo D’Attola, Caterina De Sarro, Giovambattista De Sarro, Roberta Roberti, Adele Emanuela De Francesco, Maria Diana Naturale, Domenico D’Amico, Stefano Dastoli, Luigi Bennardo, Emilio Russo, Caterina Palleria, Giancarlo Valenti, Antonia Manti

المصدر: PLoS ONE, Vol 15, Iss 11, p e0241575 (2020)
PLoS ONE

مصطلحات موضوعية: Male, NSAIDs, Steroid Therapy, Pharmacovigilance, 030207 dermatology & venereal diseases, 0302 clinical medicine, Medicine and Health Sciences, Prospective Studies, Analgesics, Multidisciplinary, Pharmaceutics, Drugs, Middle Aged, Italy, Tolerability, Research Design, 030220 oncology & carcinogenesis, Medicine, Female, Research Article, medicine.drug, Adult, medicine.medical_specialty, Drug Research and Development, Drug Administration, Drug-Related Side Effects and Adverse Reactions, Clinical Research Design, Corticosteroid Therapy, Science, Immunology, Psoriatic Arthritis, Research and Analysis Methods, Autoimmune Diseases, 03 medical and health sciences, Psoriatic arthritis, Drug Therapy, Drug Safety, Rheumatology, Internal medicine, Ustekinumab, medicine, Adalimumab, Psoriasis, Adverse Drug Reaction Reporting Systems, Humans, Adverse effect, Aged, Pharmacology, Biological Products, business.industry, Arthritis, Biology and Life Sciences, medicine.disease, Pain management, Infliximab, Quality of Life, Clinical Immunology, Secukinumab, Adverse Events, Clinical Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbbf672bca8758b41c77e7ca7c17b58aTest
https://doi.org/10.1371/journal.pone.0241575Test

المؤلفون: Luigi Francesco Iannone, Luigi Bennardo, Caterina Palleria, Roberta Roberti, Caterina De Sarro, Maria Diana Naturale, Stefano Dastoli, Luca Donato, Antonia Manti, Giancarlo Valenti, Domenico D’Amico, Santo D’Attola, Adele Emanuela De Francesco, Vincenzo Bosco, Eugenio Donato Di Paola, Steven Paul Nisticò, Rita Citraro, Emilio Russo, Giovambattista De Sarro

العلاقة: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241575Test; https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0241575&type=printableTest

الإتاحة: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241575Test
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0241575&type=printableTest